Legal & General Group’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$973K Buy
104,853
+450
+0.4% +$4.18K ﹤0.01% 2250
2025
Q1
$765K Sell
104,403
-380
-0.4% -$2.79K ﹤0.01% 2269
2024
Q4
$895K Buy
104,783
+1,164
+1% +$9.94K ﹤0.01% 2278
2024
Q3
$901K Buy
103,619
+4,944
+5% +$43K ﹤0.01% 2271
2024
Q2
$675K Buy
98,675
+86,561
+715% +$592K ﹤0.01% 2322
2024
Q1
$110K Buy
12,114
+3,641
+43% +$33.1K ﹤0.01% 2730
2023
Q4
$37.8K Sell
8,473
-436
-5% -$1.95K ﹤0.01% 2846
2023
Q3
$28K Sell
8,909
-725
-8% -$2.28K ﹤0.01% 2937
2023
Q2
$49.7K Buy
9,634
+326
+4% +$1.68K ﹤0.01% 2878
2023
Q1
$49.1K Buy
9,308
+439
+5% +$2.31K ﹤0.01% 2881
2022
Q4
$24.9K Hold
8,869
﹤0.01% 3109
2022
Q3
$37K Sell
8,869
-382
-4% -$1.59K ﹤0.01% 3045
2022
Q2
$37K Sell
9,251
-44,299
-83% -$177K ﹤0.01% 3063
2022
Q1
$265K Hold
53,550
﹤0.01% 2577
2021
Q4
$374K Buy
53,550
+19,498
+57% +$136K ﹤0.01% 2506
2021
Q3
$341K Buy
34,052
+12,533
+58% +$126K ﹤0.01% 2531
2021
Q2
$305K Buy
21,519
+173
+0.8% +$2.45K ﹤0.01% 2432
2021
Q1
$350K Sell
21,346
-114
-0.5% -$1.87K ﹤0.01% 2359
2020
Q4
$445K Buy
21,460
+14,243
+197% +$295K ﹤0.01% 2284
2020
Q3
$55K Sell
7,217
-1,237
-15% -$9.43K ﹤0.01% 2663
2020
Q2
$70K Buy
8,454
+1,649
+24% +$13.7K ﹤0.01% 2623
2020
Q1
$34K Sell
6,805
-1,554
-19% -$7.76K ﹤0.01% 2724
2019
Q4
$33K Buy
8,359
+1,682
+25% +$6.64K ﹤0.01% 3003
2019
Q3
$20K Hold
6,677
﹤0.01% 3129
2019
Q2
$29K Hold
6,677
﹤0.01% 3045
2019
Q1
$27K Buy
6,677
+1,835
+38% +$7.42K ﹤0.01% 2978
2018
Q4
$19K Hold
4,842
﹤0.01% 3102
2018
Q3
$33K Hold
4,842
﹤0.01% 2980
2018
Q2
$33K Sell
4,842
-241
-5% -$1.64K ﹤0.01% 2970
2018
Q1
$33K Sell
5,083
-892
-15% -$5.79K ﹤0.01% 2944
2017
Q4
$27K Hold
5,975
﹤0.01% 3094
2017
Q3
$38K Hold
5,975
﹤0.01% 2996
2017
Q2
$55K Buy
5,975
+2,930
+96% +$27K ﹤0.01% 2892
2017
Q1
$28K Hold
3,045
﹤0.01% 2995
2016
Q4
$25K Buy
+3,045
New +$25K ﹤0.01% 3078